Polymorphisms in the gene for lymphotoxin-α predispose to chronic chagas cardiomyopathy

Journal of Infectious Diseases

Volumn 196, Issue 12, 2007, Pages 1836-1843

  Ramasawmy, Rajendranath ^a,b,c   Fae, Kellen C ^a,b   Cunha Neto, Edecio ^a,b   Müller, Natalie G ^a,b   Cavalcanti, Vanessa L ^a,b   Ferreira, Renata C ^a   Drigo, Sandra A ^a   Ianni, Barbara ^a   Mady, Charles ^a   Goldberg, Anna C ^a,b   Kalil, Jorge ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Millennium Institute   (Brazil)

^c Millenium Institute   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; ANIMAL; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MIDDLE AGED;

ANIMALS; CHAGAS CARDIOMYOPATHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149138134     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/523653     Document Type: Article

References (36)

1. Control of Chagas' disease: second report of the WHO Expert Committee. Tech rep ser 905. Geneva: World Health Organization, 2002.
2. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002; 18:262-5.
3. Higuchi ML, De Morais CF, Pereira Barreto AC, et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 1987; 10: 665-70.
4. Barretto AC, Mady C, Nussbacher A, et al. Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. Int J Cardiol 1998; 67:19-25.
5. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol 2005; 102:239-47.
6. Parada H, Carrasco HA, Anez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 1997; 60:49-54.
7. Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy: the pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology 1995; 86:1-7.
8. Tanaka T, Ozaki K. Inflammation as a risk factor for myocardial infarction. J Hum Genet 2006; 51:595-604.
9. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-26.
10. Ware CF, VanArsdale S, VanArsdale TL. Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 1996; 60: 47-55.
11. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32:650-4.
12. Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 2004; 36:394-9.
13. Ramasawmy R, Cunha-Neto E, Fae KC, et al. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin Infect Dis 2006; 43:305-11.
14. Barretto AC, Arteaga E, Mady C, Ianni BM, Bellotti G, Pileggi F. Male sex: prognostic factor in Chagas' disease. Arq Bras Cardiol 1993; 60: 225-7.
15. Basquiera AL, Sembaj A, Aguerri AM, et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003; 89:1186-90.
16. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78:629-44.
17. Reis DD, Jones EM, Tostes S Jr, et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993; 48:637-44.
18. Menezes CA, Rocha MO, Souza PE, Chaves AC, Gollob KJ, Dutra WO. Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 2004; 137:129-38.
19. Ferreira RC, Ianni BM, Abel LC, et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003; 98:407-11.
20. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-α in chagasic cardiomyopathy. Clin Infect Dis 2004; 38:943-50.
21. Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 2005; 98:97-102.
22. Beraun Y, Nieto A, Collado MD, Gonzalez A, Martin J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 1998; 52:81-3.
23. Drigo SA, Cunha-Neto E, Ianni B, et al. Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 2007; 108:109-11.
24. Higuchi MD, Ries MM, Aiello VD, et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 1997; 56: 485-9.
25. Benvenuti LA, Higuchi ML, Reis MM. Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol 2000; 9:111-7.
26. Browning JL, Sizing ID, Lawton P, et al. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J Immunol 1997; 159:3288-98.
27. Schreyer SA, Peschon JJ, LeBoeuf RC. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 1996; 271: 26174-8.
28. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 1997; 186:1233-40.
29. Cuff CA, Schwartz J, Bergman CM, Russell KS, Bender JR, Ruddle NH. Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. J Immunol 1998; 161:6853-60.
30. Kumaraguru U, Davis IA, Deshpande S, Tevethia SS, Rouse BT. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol 2001; 166:1066-74.
31. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173:209-19.
32. Kubota T, McNamara DM, Wang JJ, et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97:2499-501.
33. Magez S, Stijlemans B, Caljon G, Eugster HP, De Baetselier P. Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction. Infect Immun 2002; 70:1342-51.
34. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 2002; 195:1371-7.
35. Schreyer SA, Vick CM, LeBoeuf RC. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 2002; 277:12364-8.
36. Keso T, Perola M, Laippala P, et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154:691-7.